In a research report published Tuesday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on XOMA Corp (NASDAQ:XOMA) with a price target of $17, after …
Wedbush analyst Liana Moussatos has high hopes for Receptos Inc (NASDAQ:RCPT), reiterating an Outperform rating on the stock, while increasing the company’s acquisition value to $348 (from $211). …
MannKind Corporation (NASDAQ:MNKD) shares increased more than 2% in pre-market trading to $6.25 after Shaunak Deepak, an analyst at Jefferies, reiterated a Buy …
On June 2, Wedbush analyst Liana Moussatos published a list of upcoming catalysts for emerging pharmaceuticals, specifically for Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Receptos …
In a research report published Thursday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on XOMA Corp (NASDAQ:XOMA) with a $17 price target, after …
On May 19, Intercept Pharmaceuticals Inc (NASDAQ:ICPT) announced plans for an international Phase 3 trial of OCA in patients with NASH. Although this …
Wedbush analyst Liana Moussatos weighed in today with a few insights on Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after the company announced the design of its …
On May 11, Intercept Pharmaceuticals Inc (NASDAQ:ICPT) reported first quarter earnings for 2015. The biopharmaceutical company does not yet have any approved products …
In a research note issued today, Wedbush analyst Liana Moussatos reiterated an Outperform rating on Intercept Pharmaceuticals Inc (NASDAQ:ICPT) with a $493 price …
On April 6, analysts at Wedbush led by Liana Moussatos highlighted upcoming events in the biotech sector. Here is what to watch for: OvaScience Inc …
